JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 20, 2006; DOI: 10.1124/jpet.106.103390


0022-3565/06/3181-395-402$20.00
JPET 318:395-402, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.103390v1
318/1/395    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Pang, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Pang, K. S.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Vectorial Transport of Enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in Rat and Human Livers

Lichuan Liu1, Yunhai Cui, Alfred Y. Chung, Yoshihisa Shitara, Yuichi Sugiyama, Dietrich Keppler, and K. Sandy Pang

Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada (L.L., K.S.P.); Division of Tumor Biochemistry, German Cancer Research Center, Heidelberg, Germany (Y.C., D.K.); Protein Core Facility, University of Florida, Gainesville, Florida (A.Y.C.); Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (Y.Sh.); and Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan (Y.Su.)

Although Oatp1a1 (rat organic anion-transporting polypeptide 1a1) was the transporter found responsible for the hepatocellular entry of enalapril (EN) into the rat liver, the canalicular transporter involved for excretion of EN and the metabolite, enalaprilat (ENA), was unknown. The Eisai hyperbilirubinemic rat (EHBR) that lacks Mrp2 (multidrug resistance-associated protein 2) was used to appraise the role of Mrp2 in the excretion of [3H]EN and its metabolite [3H]ENA in single-pass rat liver preparations. Although the total and metabolic clearances and hepatic extraction ratios at steady-state were virtually unaltered for EN in EHBR compared with published values of Sprague-Dawley rats, the biliary clearances of EN and ENA were significantly reduced almost to zero (P < 0.05). Involvement of human OATP1B1, OATP1B3, and MRP2 in EN transport was further assessed in single- or double-transfected mammalian cells. Human embryonic kidney 293 cells that expressed OATP1B1 or OATP1B3 showed that OATP1B3 transport of EN (20-500 µM) was of low affinity, whereas transport of EN by OATP1B1 was associated with the Km of 262 ± 35 µM, a value similar to that for Oatp1a1 (214 µM). The transcellular transport of EN via human OATP1B1 and MRP2, investigated with the double-transfected Madin-Darby canine kidney (MDCK) II cells in the Transwell system, showed that the sinusoidal to canalicular flux of EN in the OATP1B1/MRP2/MDCK cells was significantly higher (P < 0.05) than that of mock/MDCK and OATP1B1/MDCK cells. EN was transported by Oatp1a1 and Mrp2 in rats and OATP1B1/OATP1B3 and MRP2 in humans.


Received February 22, 2006; accepted April 19, 2006.

Address correspondence to: Dr. K. Sandy Pang, Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, ON, Canada M5S 2S2. E-mail: ks.pang{at}utoronto.ca




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. S. Kalgutkar, B. Feng, H. T. Nguyen, K. S. Frederick, S. D. Campbell, H. L. Hatch, Y.-A. Bi, D. C. Kazolias, R. E. Davidson, R. J. Mireles, et al.
Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and Human
Drug Metab. Dispos., November 1, 2007; 35(11): 2111 - 2118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Liu, H. Sun, W. Y. Valji, and K. S. Pang
Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1078 - G1088.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A.-L. Ungell, and J. Karlsson
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines
Drug Metab. Dispos., August 1, 2007; 35(8): 1333 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Planchamp, A. Hadengue, B. Stieger, J. Bourquin, A. Vonlaufen, J.-L. Frossard, R. Quadri, C. D. Becker, and C. M. Pastor
Function of Both Sinusoidal and Canalicular Transporters Controls the Concentration of Organic Anions within Hepatocytes
Mol. Pharmacol., April 1, 2007; 71(4): 1089 - 1097.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.